NCT00444041View on ClinicalTrials.gov

Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

Bevacizumab

neoadjuvant therapy prior to elective surgery

Trial Locations (1)

1090

Medical University Hospital Vienna, Vienna

All Listed Sponsors

lead

Austrian Society Of Surgical Oncology

OTHER

NCT00444041 - Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter